熱點資訊
團隊人員
1. 研究組長：侯陵研究員，博士，研究員，博士生導師。曾師從發育生物學教授劉筠院士并獲碩士學位。留學日本Tohoku大學并獲博士學位，后赴美國印第安納大學醫學院從事博士后，并先后在美國國立衛生研究院(NIH)任助理研究員，副研究員，Scientist。2008年作為海外高層次人才引進溫州醫科大學，任眼視光學與視覺科學國家重點實驗室研究員，浙江省模式生物技術與應用重點實驗室副主任。現為國家重點研發計劃評審專家、國家自然科學基金重大研究計劃和面上項目評議專家，浙江省自然基金委評審專家、中國遺傳咨詢網專家委員會成員, PLOS One的編委，The American Journal of Human Genetics, Stem Cells, Journal of Investigative Dermatology, Pigment Cell & Melanoma Research, Journal of Dermatological Science, Journal of Photochemistry & Photobiology, Experimental Dermatology, Mechanisms of Development, PLOS One, Journal of Cellular and Molecular Medicine, Differentiation等學術期刊評委。
2. 工作人員：陳瑜、麻曉銀、蘇中淵、李輝榮、王靚
研究方向
視網膜色素上皮細胞生物學與視網膜退行性病變
視網膜退行性病變是世界范圍內主要的致盲性眼病，目前尚無有效的治療方法，其重要原因之一是該類疾病的發生發展的分子機制尚未完全闡明。本團隊的研究興趣之一是視網膜發育及功能障礙中的轉錄調控及信號通路。我們通過利用先天性視網膜變性，年齡相關視網膜病變及氧化應激誘導的視網膜變性小鼠模型，結合細胞生物學技術、分子生物學技術，Chip-seq，RNA-seq高通量篩選等技術，以闡明特異性視網膜變性的分子和細胞機理。在此基礎上，我們將對小鼠采用基因療法或藥物治療，以期望找到可有效減慢或延緩視網膜退行性病變的有效治療方式。
Laboratory of Developmental Cell Biology and Disease
Team Members
1. Principal investigator: Ling Hou, MD, PhD
Dr. Ling Hou received his Ph.D. in 1992 from Tohoku University, Japan, where he worked with Takuji Takeuchi. From 1992 to 1996, he did postdoctoral training at the Indiana University School of Medicine, USA. From 1997 to 2000, he worked as a Research Associate Scientist with Heinz Arnheiter at NIH, USA. From 2000 to 2007, he was a Senior Research Fellow and then a Staff Scientist at NHGRI, NIH in USA. Now he works as a Senior Investigator of Cell Biology, and Molecular Genetic and Developmental Genetic Ophthalmology at State Key Laboratory of Ophthalmology, Optometry and Vision Science in China, where his program continually investigates the molecular and cellular mechanisms underlying RPE cell & melanocyte biology and retinal degeneration.
2. Team Staff：Yu Chen，Xiaoyin Ma, Zhongyuan Su，Huirong Li，Jing Wang
Scope of Research Proposal
Retinal Pigment Epithelial Cell Biology and Retinal Degeneration
Retinal degeneration is the leading cause of blindness in the world, which still lacks effective treatments. One of the reasons is the molecular mechanisms of the retinal degeneration have not been fully understood. Our research interest is the transcriptional regulation and signaling pathways in retinal development and dysfunctions. We use the congenital retinal degeneration, age-related retinal degeneration, and stress induced retinal generation mice models, combined with cellular biology, molecular biology and high throughput assays, such as ChIP-seq, RNA-seq to elucidate the molecular and cellular mechanisms of the specific retinal degeneration. Based on the elucidated mechanisms, we will use the gene therapy or drug treatment to treat the mice, we hope we can find effective ways to delay or slow down the retinal degeneration.
掃碼預約掛號
Copyright 2017 ? 版權所有 溫州醫科大學附屬眼視光醫院 浙ICP備05076115號-3
技術支持：溫州醫科大學附屬眼視光醫院信息管理處 聯科科技
